BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6454219)

  • 1. [Immunological changes with prognostic significance in malignant pharyngo-laryngeal tumors].
    Suceava I; Simu G
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):53-8. PubMed ID: 6454219
    [No Abstract]   [Full Text] [Related]  

  • 2. [The relationship between the degree of dissemination of pharyngolaryngeal tumours and immunological changes (author's transl)].
    Suceava I; Simu G
    Ann Otolaryngol Chir Cervicofac; 1977 Mar; 94(3):83-93. PubMed ID: 327897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follow-up of the immunological condition of patients with malignant otolaryngolgic tumors using the tuberculin test].
    Pihrt J; Nedvĕdová
    Cesk Otolaryngol; 1976 Apr; 25(2):80-3. PubMed ID: 1277367
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic significance of histologic host response in cancer of the larynx or hypopharynx.
    Bennett SH; Futrell JW; Roth JA; Hoye RC; Ketcham AS
    Cancer; 1971 Nov; 28(5):1255-65. PubMed ID: 5125672
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
    Maisel RH; Ogura JH
    Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune functions in cancers of the upper respiratory and digestive tracts].
    Follézou JY; Bayssas M; Provost MA; Fridman WH; Dumont J; Point D; Brugère J
    Nouv Presse Med; 1978 Oct; 7(37):3368. PubMed ID: 733515
    [No Abstract]   [Full Text] [Related]  

  • 7. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
    Berlinger NT; Hilal EY; Oettgen HF; Good RA
    Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systematic immunological monitoring of patients with laryngeal cancer: cell-mediated immunity].
    Sartoris A; Cortesina G; Morra B; Bussi M; Tabaro G
    Ann Laringol Otol Rinol Faringol; 1979; 77(1-2):81-7. PubMed ID: 547788
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx.
    Ghoneum M; Gill G; Perry L
    Laryngoscope; 1986 Nov; 96(11):1300. PubMed ID: 3773632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological surveillance of otorhinolaryngological cancers].
    Bagarry D; Favre R; Imbert J; Jausseran M; Meyer G; D'Istria JC; Serafino X
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Dec; 23(10):852-9. PubMed ID: 4282092
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological status of laryngeal cancer patients and the problems of nonspecific immunotherapy].
    Nasretdinov TKh; Gorodilova VV; Pogosov VS; Akopian RG
    Vestn Otorinolaringol; 1981; (4):56-61. PubMed ID: 7303375
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular immunity in 3 siblings with cancers of the upper aerodigestive tract].
    Kürten C
    Laryngorhinootologie; 1990 Jan; 69(1):21-3. PubMed ID: 2310457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Values of antiviral antibodies in the plasma of the patients with otorhinolaryngologic cancer].
    Takasu T; Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Jul; 73(7 Suppl):Suppl:1074-5. PubMed ID: 5466792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relationship between surgery, chemotherapy, irradiation and immunological state in patients of laryngeal cancer (author's transl)].
    Krajina Z; Kosoković F; Bolanca S; Bumber Z
    Laryngol Rhinol Otol (Stuttg); 1980 Jun; 59(6):341-3. PubMed ID: 6969833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of various immunologic indicators in patients with laryngopharyngeal cancer before and after administration of T-activin].
    Nummaev GM; Drevnina NA
    Vestn Otorinolaringol; 1989; (1):67. PubMed ID: 2785312
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of immunoglobulin A in patients with oral and laryngeal malignancies].
    Michalski H; Storch H; Brandl R; Fritsche T
    Stomatol DDR; 1981 Jun; 31(6):413-9. PubMed ID: 6949376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunology in cancerology laryngo-pharingeal].
    Clemente JM; López-Campos JL
    Rev Esp Otoneurooftalmol Neurocir; 1976; 34(198):65-82. PubMed ID: 996350
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relationship among lymphatic metastasis, pericancerous lymphocytic reaction and dendritic cell infiltration in laryngeal carcinoma cells].
    Feng Y; Zhang B; Tan H; Su H; He W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Aug; 36(4):264-6. PubMed ID: 12761992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.